Publications by authors named "Eva M Gamper"

Claim this Profile
Q
Quality of life in thyroid cancer survivors with and without permanent hypoparathyroidism.
Matthias Büttner, Gerasimos Sykiotis, Akram Al-Ibraheem, Monica Pinto, Ioannis Iakovou, Eva Maria Gamper

Hormones (Athens)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the Cancer-Specific Preference-Based Measure EORTC QLU-C10D against the Generic Instruments EQ-5D-5L and SF-6Dv2 in a Prospectively Collected Sample of Patients with Cancer in Austria and France.
Micha J Pilz, Simone Seyringer, Virginie Nerich, Madeleine T King, Richard Norman, Eva M Gamper

Pharmacoeconomics· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-specific utility: clinical validation of the EORTC QLU-C10D in patients with glioblastoma.
Simone Seyringer, Micha J Pilz, Andrew Bottomley, Madeleine T King, Richard Norman, Eva M Gamper

Eur J Health Econ· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical issues with methods and results interpretation at validating the EQ-5D-5L and QLU-C10D utilities in gastric cancer patients : Referring to: Pan, C. W., he, J. Y., Zhu, Y. B., Zhao, C. H., Luo, N., & Wang, P.: Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients. The European journal of health economics, 24(6), 885-893 (2003).
Simone Seyringer, Eva Maria Gamper

Eur J Health Econ· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shifting perspectives: a reflection on cancer-specific quality-of-life metrics in cancer care economics.
Eva Maria Gamper, Madeleine T King, Jim W Shaw, Anja Schiel, Zoltan Kalo

Lancet Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the cancer-specific utility measure EORTC QLU-C10D using evidence from four lung cancer trials covering six country value sets.
Simone Seyringer, Micha J Pilz, Imad Al-Naesan, Madeleine T King, Andrew Bottomley, Eva M Gamper

Sci Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to "Cancer-specific utility instrument for health economic evaluations: A synopsis of the EORTC QLU-C10D user manual and current validity evidence" [Eur J Cancer (2025) 115235].
Simone Seyringer, Micha Pilz, Femke Jansen, Matthias Büttner, Madeleine T King, Eva M Gamper

Eur J Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-specific utility instrument for health economic evaluations: A synopsis of the EORTC QLU-C10D user manual and current validity evidence.
Simone Seyringer, Micha Johannes Pilz, Femke Jansen, Matthias Büttner, Madeleine T King, Eva M Gamper

Eur J Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the Netherlands.
Micha J Pilz, Simon Seyringer, Lára R Hallsson, Andrew Bottomley, Femke Jansen, Eva Maria Gamper

Eur J Health Econ· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cancer-Specific Health Economic Measure QLU-C10D is Valid and Responsive for Assessing Health Utility in Patients with Thyroid Cancer.
Micha J Pilz, Simone Seyringer, Susanne Singer, Georgios Ioannidis, Gerasimos P Sykiotis, Eva M Gamper

Thyroid· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-Specific Health Utilities: Evaluation of Core Measurement Properties of the EORTC QLU-C10D in Lung Cancer Patients-Data from Four Multicentre LUX-Lung Trials, Applying Six Country Tariffs.
Micha J Pilz, Simone Seyringer, Imad Al-Naesan, Madeleine T King, Andrew Bottomley, Eva Maria Gamper

Pharmacoecon Open· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of electronic versus paper-based data capture on data collection logistics and on missing scores in thyroid cancer patients.
Susanne Singer, Gerasimos Sykiotis, Akram Al-Ibraheem, Monica Pinto, Ioannis Iakovou, Eva Maria Gamper

Endocrine· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types.
Jammbe Z Musoro, Corneel Coens, Mirjam A G Sprangers, Yvonne Brandberg, Mogens Groenvold, Eva M Gamper

Eur J Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The European Organisation for Research and Treatment of Cancer Quality of Life Utility-Core 10 Dimensions: Development and Investigation of General Population Utility Norms for Canada, France, Germany, Italy, Poland, and the United Kingdom.
Micha Johannes Pilz, Sandra Nolte, Gregor Liegl, Madeleine King, Richard Norman, Eva Maria Gamper

Value Health· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials.
Eva M Gamper, Jammbe Z Musoro, Corneel Coens, Jean-Jacques Stelmes, Claudette Falato

BMC Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The EORTC QLU-C10D was more efficient in detecting clinical known group differences in myelodysplastic syndromes than the EQ-5D-3L.
Eva M Gamper, Francesco Cottone, Kathrin Sommer, Richard Norman, Madeleine King

J Clin Epidemiol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
French Value-Set of the QLU-C10D, a Cancer-Specific Utility Measure Derived from the QLQ-C30.
Virginie Nerich, Eva Maria Gamper, Richard Norman, Madeleine King, Bernhard Holzner

Appl Health Econ Health Policy· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in neuroendocrine neoplasia: a critical review.
Benjamin Easton White, Maralyn R Druce, Simona Grozinsky-Glasberg, Rajaventhan Srirajaskanthan, Eva Maria Gamper

Endocr Relat Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Following patient pathways to psycho-oncological treatment: Identification of treatment needs by clinical staff and electronic screening.
Fanny L Loth, Verena Meraner, Bernhard Holzner, Susanne Singer, Irene Virgolini, Eva M Gamper

Psychooncology· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The EORTC module for quality of life in patients with thyroid cancer: phase III.
Susanne Singer, Susan Jordan, Laura D Locati, Monica Pinto, Iwona M Tomaszewska, Eva M Gamper

Endocr Relat Cancer· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Noncompletion Bias and Long-Term Adherence in a 10-Year Patient-Reported Outcome Monitoring Program in Clinical Routine.
Eva Maria Gamper, Virginie Nerich, Monika Sztankay, Caroline Martini, Johannes M Giesinger

Value Health· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality-of-Life Priorities in Patients with Thyroid Cancer: A Multinational European Organisation for Research and Treatment of Cancer Phase I Study.
Susanne Singer, Olga Husson, Iwona M Tomaszewska, Laura D Locati, Naomi Kiyota, Eva M Gamper

Thyroid· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-utility analyses of drug therapies in breast cancer: a systematic review.
Virginie Nerich, Sopany Saing, Eva Maria Gamper, Georg Kemmler, Franck Daval

Breast Cancer Res Treat· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Computer-based Health Evaluation Software (CHES): a software for electronic patient-reported outcome monitoring.
Bernhard Holzner, Johannes M Giesinger, Jakob Pinggera, Stefan Zugal, Felix Schöpf, Eva M Gamper

BMC Med Inform Decis Mak· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life trajectory in patients with advanced cancer during the last year of life.
Johannes M Giesinger, Lisa M Wintner, Anne S Oberguggenberger, Eva M Gamper, Michael Fiegl

J Palliat Med· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis